Global Staphylococcal Infection Drugs Market 2019-2023

The global staphylococcal infection drugs market size will grow by USD 684.01 million during 2019-2023. The staphylococcal infection drugs market report provides a detailed analysis of the market by product (beta-lactams, peptides, quinolones, macrolides, and others) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors including Allergan Plc, Bayer AG, GlaxoSmithKline Plc, Merck & Co. Inc., and Pfizer Inc.

To identify growth opportunities in the staphylococcal infection drugs market, the market has been segmented into regions that are growing faster than the overall market. These regions have been pitted against regions that have a slower growth rate than the global market in 2018-2023. Europe and North America will grow faster than the overall market. The growth of Asia and ROW will be slower than the global market.

Global Staphylococcal infection drugs market is expected to witness a CAGR of about 2.7% during the forecast period. Certain factors that are driving the market growth include increasing incidence of staphylococcal infections, rise in the use of antibiotics, and special drug designations.

Some of the key findings from our staphylococcal infection drugs market forecast report are summarized below

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from the staphylococcal infection drugs market report.

Get a FREE sample now!

The increased incidence of staphylococcal infections is due to the emergence of antibiotic-resistant staphylococcal strains such as Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Staphylococcus aureus (VRSA). The staphylococcal infections are known to develop in hospitals and other healthcare settings such as dialysis centers and nursing homes.  According to the NHS, 846 cases of hospital-associated MRSA bloodstream infections were reported in the April 2017-March 2018 period in the UK. According to the CDC, it was estimated that more than 119,000 people in the US suffered from bloodstream Staphylococcus aureus in 2017. Furthermore, skin and soft tissue infections caused by staphylococcus. Hence, the increasing incidence of staphylococcal infections is driving the growth of the market.

Global staphylococcal infection drugs industry overview

The staphylococcal infection drugs market is witnessing the development of several improved screening methodologies involving the phenotypic and genotypic characterization of antimicrobial resistance present in bacterial isolates. High-throughput screening is one of the highly advanced screening methodologies and has undergone improvement in terms of the utilization of picodroplets for assessing and isolating MRSA in a label-free manner. Similarly, electro-chemical phenotyping is also gaining popularity for detecting antibiotic-resistant bacteria. These advanced screening technologies will help in identifying rare antibiotic-resistant mutants and aid in the development of novel drugs. The development of advanced technologies to screen antibiotic-resistant strains will be a critical trend that will have a positive impact on the growth of the staphylococcal infection drugs market.

The consumption of antibiotics including staphylococcal infection drugs has increased significantly especially in low and middle-income countries. They are an ideal option for the treatment of several infectious diseases. The therapeutic benefits and affordability of antibiotics have led to significant growth in consumption across the world. The rapid economic development in countries such as India, China, and Pakistan have further boosted the demand for antibiotic drugs. As a result of these factors, staphylococcal infection drugs market will register a CAGR of almost 3% during the forecast period.

Top companies covered in the staphylococcal infection drugs market research report

The global staphylococcal infection drugs market is fragmented. To help clients improve their market position, the staphylococcal infection drugs market report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this staphylococcal infection drugs market analysis report also provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.

The report offers a detailed analysis of several leading staphylococcal infection drugs manufacturers, including:

• Allergan Plc
• Bayer AG
• GlaxoSmithKline Plc
• Merck & Co. Inc.
• Pfizer Inc.

Staphylococcal infection drugs market segmentation based on product

• Beta-lactams
• Peptides
• Quinolones
• Macrolides
• Others

The beta-lactams segment will account for the largest staphylococcal infection drugs market share. New drug approvals and the presence of promising beta-lactams in the pipeline are some of the factors contributing to the growth of the staphylococcal infection drugs market in this segment.

Staphylococcal infection drugs market segmentation based on geographic region

• Asia
• Europe
• North America
• ROW

With a complete study of the growth opportunities for companies, it has been identified that Asia will account for the largest staphylococcal infection drugs market share throughout the forecast period. Factors such as the increasing use of antibiotics in countries such as China and India, the high prevalence of staphylococcal infection, and the rising awareness about the need to manage and prevent infectious diseases will drive staphylococcal infection drugs market growth in this region.

Key highlights of the global staphylococcal infection drugs market for the forecast years 2019-2023:

• CAGR of the market during the forecast period 2019-2023
• Detailed information on factors that will accelerate the growth of the staphylococcal infection drugs market during the next five years
• Precise estimation of the global staphylococcal infection drugs market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the staphylococcal infection drugs industry across Asia, Europe, North America, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on several vendors
• Comprehensive details of factors that will challenge the growth of staphylococcal infection drugs companies 

We can help! Our analysts can customize the staphylococcal infection drugs market research report to meet your requirements. Get in touch